Formic Acid

Formic Acid

SCHEMBL7768566

Cc1ccc(S(=O)(=O)O)cc1.O=CO

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1BMXBRAFBTKCHRNA4CHRNB2CSNK1EEGFRERBB2F10FLT1FLT3FLT4IGF1RINSRITKJAK3KDRKITOPRM1PARP1PARP2PDGFRBPIK3CDRAF1RETSLC18A2TECTXKdacAdacBdacCftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Formic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.52
TLR9 Q9NR96 1/20 0.52
ALDH1A1 P00352 5/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
LMNA P02545 2/20 0.51
TDP1 Q9NUW8 2/20 0.51
KDM4E B2RXH2 1/20 0.51
MAPT P10636 1/20 0.51
HTT P42858 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
SNCA P37840 1/20 0.49
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
MMP1 P03956 1/20 0.48
MMP2 P08253 1/20 0.48
MMP9 P14780 1/20 0.48
MMP8 P22894 1/20 0.48
MMP13 P45452 1/20 0.48
TSHR P16473 2/20 0.48
CA12 O43570 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL28324384 0.94 ALDH1A1 (0.47) GAATLR9ALDH1A1SMN1; SMN2LMNA
SCHEMBL9517473 0.91 GAA (0.52) GAATLR9ALDH1A1SMN1; SMN2LMNA
SCHEMBL5068661 0.91 GAA (0.62) GAATLR9ALDH1A1SMN1; SMN2LMNA
SCHEMBL31313 0.91 GAA (0.62) GAATLR9ALDH1A1SMN1; SMN2LMNA
P-Xylene SCHEMBL8660591 0.91 GAA (0.62) GAATLR9ALDH1A1SMN1; SMN2LMNA
SCHEMBL29991938 0.91 GAA (0.62) GAATLR9ALDH1A1SMN1; SMN2LMNA
SCHEMBL11432043 0.91 GAA (0.62) GAATLR9ALDH1A1SMN1; SMN2LMNA
SCHEMBL1705904 0.91 GAA (0.62) GAATLR9ALDH1A1SMN1; SMN2LMNA
SCHEMBL34 0.91 GAA (0.62) GAATLR9ALDH1A1SMN1; SMN2LMNA
Phosphine SCHEMBL3185895 0.88 GAA (0.59) GAATLR9ALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160115601-A1 ELECTROCHEMICAL PROCESS FOR PRODUCTION OF GRAPHENE UNIV MANCHESTER (GB) 2016-04-28 US claimed
EP-3004423-A1 ELECTROCHEMICAL PROCESS FOR PRODUCTION OF GRAPHENE The University Of Manchester (GB) 2016-04-13 EP claimed
WO-2014191765-A1 ELECTROCHEMICAL PROCESS FOR PRODUCTION OF GRAPHENE THE UNIVERSITY OF MANCHESTER (GB) 2014-12-04 WO claimed
EP-3030693-B1 PRODUCTION OF GRAPHENE AND GRAPHANE UNIV MANCHESTER (GB) 2020-05-13 EP disclosed
CN-110382485-A Heterocycle ene derivative as pest control agent 拜耳公司 2019-10-25 CN disclosed
CN-110312718-A HETEROCYCLENE DERIVATIVES AS PEST CONTROL AGENTS 拜耳公司 2019-10-08 CN disclosed
CN-106414441-B9 2- (hetero) aryl-substituted fused bicyclic heterocyclic derivatives as pest control agents 拜耳作物科学股份公司 2019-09-20 CN disclosed
CN-110248941-A The imidazopyridine derivatives that aryl or heteroaryl replace and its purposes as pesticide 拜耳公司 2019-09-17 CN disclosed
US-10415143-B2 Production of graphene and graphane THE UNIVERSITY OF MANCHESTER (GB) 2019-09-17 US disclosed
CN-106414441-B 2- (hetero) aryl-substituted fused bicyclic heterocyclic derivatives as pest control agents 拜耳作物科学股份公司 2019-08-13 CN disclosed
CN-110062756-A 2- (hetero) aryl-substituted fused bicyclic heterocyclic derivatives as pest control agents 拜耳作物科学股份公司 2019-07-26 CN disclosed
EP-3004423-A1 ELECTROCHEMICAL PROCESS FOR PRODUCTION OF GRAPHENE The University Of Manchester (GB) 2016-04-13 EP disclosed
WO-2015019093-A1 PRODUCTION OF GRAPHENE AND GRAPHANE THE UNIVERSITY OF MANCHESTER (GB) 2015-02-12 WO disclosed
WO-2014191765-A1 ELECTROCHEMICAL PROCESS FOR PRODUCTION OF GRAPHENE THE UNIVERSITY OF MANCHESTER (GB) 2014-12-04 WO disclosed
EP-1112303-A2 CURING OF RESINS Chemcolloids Limited (GB) 2001-07-04 EP disclosed
CN-1287117-A Cyclobutene derivatives, preparation method and therapeutic use thereof SANKYO CO (JP) 2001-03-14 CN disclosed
WO-2000015694-A2 CURING OF RESINS CHEMCOLLOIDS LIMITED (GB) 2000-03-23 WO disclosed
WO-1998006723-A1 AMINE SALTS BIOCHEMIE GESELLSCHAFT MBH (AT) 1998-02-19 WO disclosed
EP-0009548-A2 Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-04-16 EP disclosed
US-4104280-A Dibenzo [b.f]thiepin and dibenzo[b.f]oxepin derivatives SYNTEX (U.S.A.) INC. (US) 1978-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10415143-B2 Production of graphene and graphane GRN, GYPA, GJA1 GAA 3249/4885TLR9 2117/4885ALDH1A1 2880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.